Pancreatic Inflammation Redirects Acinar to β Cell Reprogramming.

Area of Science:

• Cellular reprogramming
• Diabetes research
• Transgenic mouse models

Background:

• Pancreatic acinar cells can be reprogrammed into insulin-producing beta-like cells.
• Transcription factors like MafA, Pdx1, and Neurog3 (3TF) are key drivers of this reprogramming.
• Inflammation can significantly impact the success of cellular reprogramming.

Purpose of the Study:

• To investigate the role of transcription factor expression magnitude and inflammation in acinar-to-beta-like cell reprogramming.
• To determine the conditions necessary for generating functional beta-like cells from pancreatic acinar cells.
• To assess the therapeutic potential of reprogrammed beta-like cells in a diabetes model.

Main Methods:

• Utilized a transgenic mouse model for doxycycline-inducible expression of MafA, Pdx1, and Neurog3 (3TF) in pancreatic acinar cells.
• Manipulated 3TF expression levels and macrophage populations to study reprogramming outcomes.
• Evaluated beta-like cell generation, inflammation, and functional recovery in a streptozotocin-induced diabetes model.

Main Results:

• High 3TF expression led to acinar cell necrosis and inflammation, hindering beta-like cell generation.
• Reducing 3TF expression or eliminating macrophages mitigated inflammation and promoted beta-like cell formation.
• Newly generated beta-like cells transiently reversed streptozotocin-induced diabetes but lost function upon withdrawal of reprogramming factors.

Conclusions:

• Successful generation of functional beta-like cells via 3TF reprogramming requires careful control of both factor expression and the inflammatory response.
• Inflammation, particularly macrophage-driven, is a critical barrier to effective acinar-to-beta-like cell conversion.
• While promising for transient diabetes reversal, sustained function of reprogrammed cells remains a challenge.